![Markus Loeffler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Markus Loeffler
Directeur Technique/Scientifique/R&D chez NH THERAGUIX SAS
Profil
Markus Loeffler is currently the Chief Medical Officer at NH TherAguix SAS since 2020.
He holds a Master's in Business Administration from INSEAD.
Postes actifs de Markus Loeffler
Sociétés | Poste | Début |
---|---|---|
NH THERAGUIX SAS | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Formation de Markus Loeffler
INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
NH TherAguix SAS
![]() NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |